Research graph
References from Assessment of muscle damage in patients with advanced Duchenne muscular dystrophy based on serum creatinine and the height-to-creatinine ratio. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1002/jcsm.70284 · 2026 · Admitted local publication
Identifying non-Duchenne muscular dystrophy-positive and false negative results in prior Duchenne muscular dystrophy newborn screening programs: a review
10.1001/jamaneurol.2015.3537 · 2016 · External reference
Muscle MRI in Duchenne muscular dystrophy: evidence of a distinctive pattern
10.1016/j.nmd.2016.09.002 · 2016 · External reference
Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study
10.1016/s0140-6736(17)32160-8 · 2018 · External reference
Timed function tests, motor function measure, and quantitative thigh muscle MRI in ambulant children with Duchenne muscular dystrophy: a cross-sectional analysis
10.1016/j.nmd.2017.10.003 · 2018 · External reference
Quantitative MRI Findings and their relationship to muscle histopathology and ambulatory clinical function in Duchenne muscular dystrophy
10.1002/jcsm.70205 · 2026 · External reference
Titin fragment is a sensitive biomarker in Duchenne muscular dystrophy model mice carrying full-length human dystrophin gene on human artificial chromosome
10.1038/s41598-025-85369-5 · 2025 · External reference
Serum titin/creatinine ratio as a biomarker for discriminating disease severity in Duchenne and Becker muscular dystrophies
10.3389/fneur.2025.1591748 · 2025 · External reference
Serum creatinine level: a supplemental index to distinguish Duchenne muscular dystrophy from Becker muscular dystrophy
10.1155/2015/141856 · 2015 · External reference
Genetics and emerging treatments for Duchenne and Becker muscular dystrophy
10.1016/j.pcl.2015.03.008 · 2015 · External reference
10.3760/cma.j.cn112147-20250826-00518
10.3760/cma.j.cn112147-20250826-00518 · 2026 · External reference
Duchenne muscular dystrophy: MR grading system with functional correlation
10.1148/radiology.186.2.8421754 · 1993 · External reference
Alterations of neuromuscular junctions in Duchenne muscular dystrophy
10.1016/j.neulet.2020.135304 · 2020 · External reference
The assessment of muscle mass in progressive neuromuscular disease
10.1212/wnl.33.2.158 · 1983 · External reference
Urinary titin reflects the severity of walking ability, muscle strength, and muscle and cardiac damage in patients with Becker muscular dystrophy
10.1016/j.cca.2024.120053 · 2025 · External reference
Creatine and creatinine metabolism
10.1152/physrev.2000.80.3.1107 · 2000 · External reference
Serum creatinine as a biomarker for dystrophinopathy: a cross-sectional and longitudinal study
10.1186/s12883-021-02382-7 · 2021 · External reference
Muscle mass and estimates of renal function: a longitudinal cohort study
10.1002/jcsm.12969 · 2022 · External reference
Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management
10.1016/s1474-4422(18)30025-5 · 2018 · External reference
Endocrine and metabolic complications in a national cohort of Slovene children and adolescents with Duchenne muscular dystrophy: real-world criteria for transition to vamorolone therapy
10.3389/fendo.2025.1697907 · 2025 · External reference
Causal linkage between adult height and kidney function: an integrated population-scale observational analysis and Mendelian randomization study
10.1371/journal.pone.0254649 · 2021 · External reference
Relation between obesity-related comorbidities and kidney function estimation in children
10.1007/s00467-022-05810-z · 2023 · External reference
Age, gender, and body length effects on reference serum creatinine levels determined by an enzymatic method in Japanese children: a multicenter study
10.1007/s10157-011-0452-y · 2011 · External reference
Serum protein biomarker signature of Duchenne muscular dystrophy
10.4081/ejtm.2025.13956 · 2025 · External reference
A longitudinal study of creatine kinase and creatinine levels in Duchenne muscular dystrophy
10.1002/mus.27760 · 2023 · External reference
Proteomic profiling of mdx-4cv serum reveals highly elevated levels of the inflammation-induced plasma marker haptoglobin in muscular dystrophy
10.3892/ijmm.2017.2952 · 2017 · External reference
Novel miRNA Biomarkers for patients with Duchenne muscular dystrophy
10.3389/fneur.2022.921785 · 2022 · External reference
